✦ LIBER ✦

Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease

✍ Scribed by Boyman, Onur; Surh, Charles D; Sprent, Jonathan

Book ID: 121219773
Publisher: Informa plc
Year: 2006
Tongue: English
Weight: 407 KB
Volume: 6
Category: Article
ISSN: 5847-4714
DOI: 10.1517/14712598.6.12.1323

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characterization of a monoclonal rat ant

Characterization of a monoclonal rat anti-mouse interleukin 2 (IL-2) receptor antibody and its use in the biochemical characterization of the murine IL-2 receptor

✍ Glen N. Gaulton; James Bangs; Stephen Maddock; Timothy Springer; Diane D. Eardle 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 937 KB

Anti-IL-36R antibodies, potentially usef

Anti-IL-36R antibodies, potentially useful for the treatment of psoriasis: a patent evaluation of WO2013074569

✍ Wolf, Joel; Ferris, Laura Korb 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 120 KB

5104652 Compositions and method for trea

5104652 Compositions and method for treatment of cancer using monoclonal antibody against GD3 ganglioside together with IL-2

✍ Pryor, John; Parsons, John; Goswamy, Rajat; Matson, Phillip; Vaid, Praful; Wilso 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 70 KB

High-dose humanized anti-IL-2 receptor a

High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis

✍ Steven Yeh; Keith Wroblewski; Ronald Buggage; Zhuqing Li; Shree K. Kurup; Hatice 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 607 KB

Aβ immunization and anti-Aβ antibodies:

Aβ immunization and anti-Aβ antibodies: potential therapies for the prevention and treatment of Alzheimer’s disease

✍ David M Holtzman; Kelly R Bales; Steven M Paul; Ronald B DeMattos 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 224 KB

Blocking of interleukin 2 (IL 2) binding

Blocking of interleukin 2 (IL 2) binding to the IL 2 receptor is not required for the in vivo action of anti-IL 2 receptor monoclonal antibody (mAb). I. The production, characterization and in vivo properties of a new mouse anti-rat IL 2 receptor mAb that reacts with an epitope different to the one that binds to IL 2 and the mAb ART-18

✍ Athanasia Mouzaki; Hans-Dieter Volk; Hisao Osawa; Tibor Diamantstein 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 727 KB

A mouse anti-rat interleukin 2 (IL 2) receptor (IL 2R) monoclonal antibody (mAb), ART-65, has been developed. As shown by fluorescence-activated cell sorter analysis and immunoprecipitation studies, ART-65 recognizes in a species-specific manner the same molecule as does ART-18, a mAb which has been